Anti-Inflammatory Effects of Endogenously Released Adenosine in Synovial Cells of Osteoarthritis and Rheumatoid Arthritis Patients

Sohn, Rebecca and Junker, Marius and Meurer, Andrea and Zaucke, Frank and Straub, Rainer H. and Jenei-Lanzl, Zsuzsa (2021) Anti-Inflammatory Effects of Endogenously Released Adenosine in Synovial Cells of Osteoarthritis and Rheumatoid Arthritis Patients. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22 (16): 8956. ISSN , 1422-0067

Full text not available from this repository. (Request a copy)

Abstract

Exogenous adenosine and its metabolite inosine exert anti-inflammatory effects in synoviocytes of osteoarthritis (OA) and rheumatoid arthritis (RA) patients. We analyzed whether these cells are able to synthesize adenosine/inosine and which adenosine receptors (ARs) contribute to anti-inflammatory effects. The functionality of synthesizing enzymes and ARs was tested using agonists/antagonists. Both OA and RA cells expressed CD39 (converts ATP to AMP), CD73 (converts AMP to adenosine), ADA (converts adenosine to inosine), ENT1/2 (adenosine transporters), all AR subtypes (A(1), A(2A), A(2B) and A(3)) and synthesized predominantly adenosine. The CD73 inhibitor AMPCP significantly increased IL-6 and decreased IL-10 in both cell types, while TNF only increased in RA cells. The ADA inhibitor DAA significantly reduced IL-6 and induced IL-10 in both OA and RA cells. The A(2A)AR agonist CGS 21680 significantly inhibited IL-6 and induced TNF and IL-10 only in RA, while the A(2B)AR agonist BAY 60-6583 had the same effect in both OA and RA. Taken together, OA and RA synoviocytes express the complete enzymatic machinery to synthesize adenosine/inosine; however, mainly adenosine is responsible for the anti- (IL-6 and IL-10) or pro-inflammatory (TNF) effects mediated by A(2A)- and A(2B)AR. Stimulating CD39/CD73 with simultaneous ADA blockage in addition to TNF inhibition might represent a promising therapeutic strategy.

Item Type: Article
Uncontrolled Keywords: LOW-GRADE INFLAMMATION; DEAMINASE LEVELS; RECEPTOR; FLUID; CYTOKINES; CLASSIFICATION; PATHOGENESIS; AGONISTS; THERAPY; PATHWAY; adenosine; inosine; rheumatoid arthritis; osteoarthritis; synoviocytes; inflammation
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Dr. Gernot Deinzer
Date Deposited: 13 Sep 2022 13:53
Last Modified: 13 Sep 2022 13:53
URI: https://pred.uni-regensburg.de/id/eprint/47341

Actions (login required)

View Item View Item